Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators: A Phase 2 Randomized Clinical TrialJAMA Oncol 2021 Aug 26;[EPub Ahead of Print], Y Fan, T Sun, Z Shao, Q Zhang, Q Ouyang, Z Tong, S Wang, Y Luo, Y Teng, X Wang, S Wang, Q Liu, J Feng, K Shen, Y Song, J Wang, F Ma, Q Li, P Zhang, B Xu
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.